FDA Lifts Major Warnings on Hormone Replacement Therapy

FDA lifts major warnings on hormone replacement therapy

The U.S. Food and Drug Administration (FDA) is eliminating the prominent "black box" warnings on many hormone replacement therapy (HRT) medications, signaling a major shift in how the treatment is viewed for menopausal women.

MHE Week in Review – COVID Shingles Risk, FDA Removes Menopause Therapy Warning and More

Here’s what you missed this week on Managed Healthcare Executive.

Warning label requirements on hormone replacement products are soon to be lifted

The FDA has announced it will remove health warnings on HRT products, following the recommendations of an expert panel The post Warning label requirements on hormone replacement products are soon to be lifted appeared first on Peter Attia.